Central nervous system effects of moxonidine experimental sustained release formulation in patients with mild to moderate essential hypertension. (Q35825344)
Jump to navigation
Jump to search
scientific article published in June 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Central nervous system effects of moxonidine experimental sustained release formulation in patients with mild to moderate essential hypertension. |
scientific article published in June 2003 |
Statements
Central nervous system effects of moxonidine experimental sustained release formulation in patients with mild to moderate essential hypertension (English)
Michiel J B Kemme
Jeroen P vd Post
Matthias Straub
Adam F Cohen
Joop M A van Gerven
1 reference
1 reference